The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Yearbook of Endocrinology ◽

10.1016/j.yend.2012.05.035 ◽

2012 ◽

Vol 2012 ◽

pp. 68-71

Author(s):

P.P. Toth

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ldl Cholesterol ◽

Controlled Trial ◽

Renal Protection ◽

Download Full-text

Faculty Opinions recommendation of The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11765956.12857054 ◽

2011 ◽

Author(s):

Chim Lang

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ldl Cholesterol ◽

Controlled Trial ◽

Renal Protection ◽

Download Full-text

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

10.1016/s0140-6736(11)60739-3 ◽

2011 ◽

Vol 377 (9784) ◽

pp. 2181-2192 ◽

Cited By ~ 1430

Author(s):

Colin Baigent ◽

Martin J Landray ◽

Christina Reith ◽

Jonathan Emberson ◽

David C Wheeler ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ldl Cholesterol ◽

Controlled Trial ◽

Renal Protection ◽

Download Full-text

Faculty Opinions recommendation of The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11765956.13364060 ◽

2011 ◽

Author(s):

Ihab Wahba

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ldl Cholesterol ◽

Controlled Trial ◽

Renal Protection ◽

Download Full-text

Faculty Opinions recommendation of The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11765956.793497565 ◽

2014 ◽

Author(s):

Michel Chonchol ◽

Kristen Jablonski

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ldl Cholesterol ◽

Controlled Trial ◽

Renal Protection ◽

Download Full-text

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Yearbook of Medicine ◽

10.1016/j.ymed.2011.08.055 ◽

2011 ◽

Vol 2011 ◽

pp. 190-193 ◽

Author(s):

R. Garrick

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ldl Cholesterol ◽

Controlled Trial ◽

Renal Protection ◽

Download Full-text

Effect on non-vascular outcomes of lowering LDL cholesterol in patients with chronic kidney disease: results from the Study of Heart and Renal Protection

BMC Nephrology ◽

10.1186/s12882-017-0545-2 ◽

2017 ◽

Vol 18 (1) ◽

Author(s):

C. Reith ◽

◽

N. Staplin ◽

W. G. Herrington ◽

W. Stevens ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Ldl Cholesterol ◽

Renal Protection

Download Full-text

Faculty Opinions recommendation of Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1091047.552935 ◽

2007 ◽

Author(s):

Rajiv Agarwal

Keyword(s):

Chronic Kidney Disease ◽

Randomized Controlled Trial ◽

Kidney Disease ◽

Renal Disease ◽

End Stage Renal Disease ◽

Controlled Trial ◽

Advanced Chronic Kidney Disease ◽

Randomized Controlled ◽

Stage Renal Disease ◽

Download Full-text

Faculty Opinions recommendation of Randomized controlled trial of cholecalciferol supplementation in chronic kidney disease patients with hypovitaminosis D.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717952865.793458348 ◽

2012 ◽

Author(s):

David Goldsmith

Keyword(s):

Chronic Kidney Disease ◽

Randomized Controlled Trial ◽

Kidney Disease ◽

Controlled Trial ◽

Hypovitaminosis D ◽

Randomized Controlled ◽

Cholecalciferol Supplementation

Download Full-text

Faculty Opinions recommendation of High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954671.793466054 ◽

2012 ◽

Author(s):

John Eisman

Keyword(s):

Chronic Kidney Disease ◽

Parathyroid Hormone ◽

Kidney Disease ◽

Controlled Trial ◽

High Dose ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of The role of salt intake and salt sensitivity in the management of hypertension in South Asian people with chronic kidney disease: a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718019587.793481659 ◽

2013 ◽

Author(s):

David Goldsmith

Keyword(s):

Chronic Kidney Disease ◽

Randomised Controlled Trial ◽

Kidney Disease ◽

South Asian ◽

Salt Intake ◽

Controlled Trial ◽

Salt Sensitivity ◽

Randomised Controlled ◽

Download Full-text